MedTrace Logo

Fibrin Glue After ESD for High Risk Patients of Bleeding

NCT04602689 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2024-11-29

No results posted yet for this study

Summary

It is a prospective randomized controlled study to look for effectiveness of fibrin glue to prevent bleeding in high-risk patients after endoscopic submucosal dissection in gastric neoplasm.

Conditions

  • Early Gastric Cancer
  • Gastric Adenoma

Interventions

DRUG

Human fibrinogen concentrate

Spread the Human fibrinogen concentrate/Aprotinin/Thrombin/Calcium chloride hydrate mixture on iatrogenic ulcer after ESD

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Severance Hospital

    collaborator OTHER

  • Asan Medical Center

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Eunwoo Lee, M.D. · fellowship

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-30
Primary Completion
2022-07-14
Completion
2022-07-14

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04602689 on ClinicalTrials.gov